NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
HERZLIYA, Israel and CALGARY, AB, Dec. 31, 2024 /PRNewswire/ — Innocan Pharma Corporation (the
Read more about this post on PRNewswire_Health
Trending
- Revitalizing Aging Cells: A Breakthrough Treatment for Longevity
- Long-Acting Injectables Therapeutics Market Insights 2033
- Exciting Career Opportunities in Life Sciences at Zydus
- Biotech Mergers Making Waves: Spotlight on Eli Lilly, Vidac Pharma, and GSK
- High Denial Rates for Medicare Advantage Prior Authorizations Revealed in HHS Report
- Job Market Slowdown: The Push for Lean Operations
- Johns Hopkins Reveals Significant Investment in Life Sciences
- Connecting Healthcare Innovators: Kinshuk Kocher’s Vision for Global Health Technology Investment
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60
By PRNewswire
